References
- Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17:69–79.
- Hunfeld KP, Stanek G, Straube E, et al. Quality of Lyme disease serology. Lessons from the German Proficiency Testing Program 1999–2001. A preliminary report. Wien Klin Wochenschr. 2002;114:591–600.
- Hristea A, Hristescu S, Ciufecu C, et al. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17:891–896.
- Briciu VT, Meyer F, Sebah D, et al. Real-time PCR based identification of Borrelia burgdorferi sensu lato species in ticks collected from humans in Romania. Ticks Tick-Borne Dis. 2014;5:575–581.
- Clarissou J, Song A, Bernede C, et al. Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS). Med Mal Infect. 2009;39:108–115.
- Stanek G, Wormser GP, Gray J, et al. Lyme Borreliosis. Lancet. 2012;379:461–473.
- Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13–21.
- Mygland Å, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006;13:213–215.
- Finsterer J. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies. Scand J Infect Dis. 2007;39:187–190.
- Arniaud D, Mattei JP, Pham T, et al. Coexistent dermatomyositis, relapsing polychondritis, and positive Lyme serology. A case-report. Rev Rhum Engl Ed. 1997;64:589–590.
- Waton J, Pinault AL, Truchetet F. Lyme disease could mimic dermatomyositis. Rev Med Interne. 2007;28:343–345.
- Horowitz HW, Sanghera K, Goldberg N, et al. Dermatomyositis associated with lyme disease: case report and review of lyme myositis. Clin Infect Dis. 1994;18:166–171.
- Nguyen H, Le C. Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report. J Med Case Rep. 2010;4:187.
- Blanc F, Gebl Y. [Neurologic and psychiatric manifestations of Lyme disease]. Med Mal Infect. 2007;37:435–445.
- Hassett AL, Radvanski DC, Buyske S, et al. Psychiatric comorbidity and other psychological factors in patients with “chronic Lyme disease”. Am J Med. 2009;122:843–850.
- Vaccaro M, Guarneri F, Borgia F, et al. Association of lichen sclerosus and autoimmune thyroiditis: possible role of Borrelia burgdorferi? Thyroid. 2002;12:1147–1148.
- Garment AR, Demopoulos BP. False-positive seroreactivity to Borrelia burgdorferi in a patient with thyroiditis. Int J Infect Dis. 2010;14:e373.
- Seriburi V, Ndukwe N, Chang Z, et al. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect. 2012;18:1236–1240.
- Strle F, Stanek G. Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol. 2009;37:51–110.
- Ang CW, Notermans DW, Hommes M, et al. Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots. Eur J Clin Microbiol Infect Dis. 2011;30:1027–1032.
- Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to lyme disease. N Engl J Med. 2016;374:1209–1220.
- Pue´chal X, Sibilia J. What should be done in case of persistent symptoms after adequate antibiotic treatment for Lyme disease? Curr Probl Dermatol. 2009;37:191–199.
- Hunfeld KP, Kraiczy P. When to order a western blot and how to interpret it. Curr Probl Dermatol, Basel Karger. 2009;37:169–179.
- Kalish RA, McHugh G, Granquist J, et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33:780–785.